Spartan Fund Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
CH
SCM
AIMCA
AA
UOC
GCL
FTCM
SCM
KIM
MSU
Spartan Fund Management's AONC Position: Q1 2023 in Review
Spartan Fund Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 191,063 shares — an estimated $1.92M sold.
Spartan Fund Management first reported a position in AONC in Q4 2022 and held it in 1 quarter. The position peaked at $1.92M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.
- Spartan Fund Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Spartan Fund Management sold 191,063 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.92M.
- Spartan Fund Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
- Spartan Fund Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.92M in Q4 2022.
- 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.
Based on Spartan Fund Management's 13F filing for Q1 2023, filed 9 May 2023.